Extracellular superoxide dismutase induced by dopamine in cultured astrocytes

Neurochemical Research

Volumn 38, Issue 1, 2013, Pages 32-41

  Takano, Katsura ^a   Tanaka, Nobuyuki ^a   Kawabe, Kenji ^a   Moriyama, Mitsuaki ^a   Nakamura, Yoichi ^a  

^a Osaka Prefecture University   (Japan)

Author keywords

Astrocyte; Dopamine; Extracellular superoxide dismutase; Nuclear factor B

Indexed keywords

ACETYLCYSTEINE; AMINE OXIDASE (FLAVIN CONTAINING); AMMONIUM PYRROLIDINE 1 CARBODITHIOLATE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE TRANSPORTER; GLUTATHIONE; HALOPERIDOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOENZYME; MESSENGER RNA; PARGYLINE; SKP 83566; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VANOXERINE;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN CORTEX; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; EXTRACELLULAR SPACE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; ASTROCYTES; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SPACE; NERVE TISSUE PROTEINS; NF-KAPPA B; PIPERAZINES; RATS; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; STIMULATION, CHEMICAL; SUPEROXIDE DISMUTASE;

RATTUS;

EID: 84871610202     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-012-0882-2     Document Type: Article

References (38)

1. McCord JM, Fridovich I (1969) Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244:6049-6055
2. Bowling AC, Beal MF (1995) Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci 56(14):1151-1171
3. Chan PH, Chu L, Chen SF, Carlson EJ, Epstein CJ (1990) Reduced neurotoxicity in transgenic mice overexpressing human copper-zinc-superoxide dismutase. Stroke 21:80-82
4. Kawase M, Murakami K, Fujimura M, Morita-Fujimura Y, Gasche Y, Kondo T, Scott RW, Chan PH (1999) Exacerbation of delayed cell injury after transient global ischemia in mutant mice with CuZn superoxide dismutase deficiency. Stroke 30:1962-1968
5. Keller JN, Kindy MS, Holtsberg FW, St Clair DK, Yen H-C, Germeyer A, Steiner SM, Bruce-Keller AJ, Hutchins JB, Mattson MP (1998) Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci 18(2):687-697
6. Kondo T, Reaume AG, Huang T-T, Carlson E, Murakami K, Chen SF, Hoffman EK, Scott RW, Epstein CJ, Chan PH (1997) Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J Neurosci 17(11):4180-4189
7. Li Y, Copin J-C, Reola LF, Calagui B, Gobbel GT, Chen SF, Sato S, Epstein CJ, Chan PH (1998) Reduced mitochondrial manganese-superoxide dismutase activity exacerbates glutamate toxicity in cultured mouse cortical neurons. Brain Res 814:164-170
8. Matsuyama T, Michishita H, Nakamura H, Tsuchiyama M, Shimizu S, Watanabe K, Sugita M (1993) Induction of copper-zinc superoxide dismutase in gerbil hippocampus after ischemia. J Cereb Blood Flow Met 13:135-144
9. Murakami K, Kondo T, Kawase M, Li Y, Sato S, Chen SF, Chan PH (1998) Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci 18(1):205-213
10. Marklund SL (1984) Extracellular superoxide dismutase in human tissues and human cell lines. J Clin Invest 74(4):1398-1403
11. Ohe Y, Ishikawa K, Itoh Z, Tatemoto K (1996) Cultured leptomeningeal cells secrete cerebrospinal fluid proteins. J Neurochem 67(3):964-971
12. Fukui S, Ookawara T, Nawashiro H, Suzuki K, Shima K (2002) Post-ischemic transcriptional and translational responses of ec-sod in mouse brain and serum. Free Radical Biol Med 32(3):289-298
13. Sheng H, Bart RD, Oury TD, Pearlstein RD, Crapo JD, Warner DS (1999) Mice overexpressing extracellular superoxide dismutase have increased resistance to focal cerebral ischemia. Neuroscience 88(1):185-191
14. Sheng H, Brady TC, Pearlstein RD, Crapo JD, Warner DS (1999) Extracellular superoxide dismutase deficiency worsens outcome from focal cerebral ischemia in the mouse. Neurosci Lett 267:13-16
15. Zaghloul N, Nasim M, Patel H, Codipilly C, Marambaud P, Dewey S, Schiffer WK, Ahmed M (2012) Overexpression of extracellular superoxide dismutase has a protective role against hyperoxia-induced brain injury in neonatal mice. FEBS J 279:871-881
16. Iitsuka I, Motoyoshi-Yamashiro A, Moriyama M, Kannan-Hayashi Y, Fujimoto Y, Takano K, Murakami K, Yoneda Y, Nakamura Y (2012) Extracellular superoxide dismutase in cultured astrocytes: decrease in cell-surface activity and increase in medium activity by lipopolysaccharide-stimulation. Neurochem Res (in press)
17. Schroeter ML, Mertsch K, Giese H, Müller S, Sporbert A, Hickel B, Blasig IE (1999) Astrocytes enhance radical defence in capillary endothelial cells constituting the blood-brain barrier. FEBS Lett 449:241-244
18. Stewart VC, Stone R, Gegg ME, Sharpe MA, Hurst RD, Clark JB, Heales SJR (2002) Preservation of extracellular glutathione by an astrocyte derived factor with properties comparable to extracellular superoxide dismutase. J Neurochem 83:984-991
19. Wilson JX (1997) Antioxidant defense of the brain: a role for astrocytes. Can J Physiol Pharmacol 75:1149-1163
20. Cubells JF, Rayport S, Rajendran G, Sulzer D (1994) Methamphetamine neurotoxocity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J Neurosci 14(4):2260-2271
21. Fuller RW, Hemrick-Luecke SK (1982) Further studies on the long-term depletion of striatal dopamine in iprindole-treated rats by amphetamine. Neuropharmacology 21(5):433-438
22. Jenner P (2003) Oxidative stress in Parkinson's disease. Ann Neurol 53(Suppl 3):S26-S36 (discussion S36-38)
23. Miyazaki I, Asanuma M (2008) Dopaminergic neuron-specific oxidative stress caused by dopamine itself. Acta Med Okayama 62:141-150
24. Graham DG (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 14(4):633-643
25. Berman SB, Zigmond MJ, Hastings TG (1996) Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J Neurochem 67(2):593-600
26. Spina MB, Cohen G (1989) Dopamine turnover and glutathione oxidation: implications for Parkinson disease. Proc Nat Acad Sci USA 86:1398-1400
27. Globus MY-T, Busto R, Dietrich WD, Martinez E, Valdes I, Ginsberg MD (1988) Intra-ischemic extracellular release of dopamine and glutamate is associated with striatal vulnerability to ischemia. Neurosci Lett 91:36-40
28. Takano K, Sugita K, Moriyama M, Hashida K, Hibino S, Choshi T, Murakami R, Yamada M, Suzuki H, Hori O, Nakamura Y (2011) A dibenzoylmethane derivative protects against hydrogen peroxide-induced cell death and inhibits lipopolysaccharide-induced nitric oxide production in cultured rat astrocytes. J Neurosci Res 89:955-965
29. Miyazaki I, Asanuma M, Kikkawa Y, Takeshima M, Murakami S, Miyoshi K, Sogawa N, Kita T (2011) Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity. Glia 59:435-451
30. Paz MA, Fluckiger R, Boak A, Kagan HM, Gallop PM (1991) Specific detection of quinoproteins by redox-cycling staining. J Biol Chem 266(2):689-692
31. Miyazaki I, Asanuma M, Diaz-Corrales FJ, Miyoshi K, Ogawa N (2004) Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia. Brain Res 1029:120-123
32. Youdim MBH, Bakhle YS (2006) Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness. Br J Pharmacol 147:S287-S296
33. Takeda H, Inazu M, Matsuyama T (2002) Astroglial dopamine transport is mediated by norepinephrine transporter. Naunyn-Schmiedebergs Arch Pharmacol 366:620-623
34. Fattman CL, Schaefer LM, Oury TD (2003) Extracellular superoxide dismutase in biology and medicine. Free Radical Biol Med 35(3):236-256
35. Hirrlinger J, Schulz JB, Dringen R (2002) Effects of dopamine on the glutathione metabolism of cultured astroglial cells: implications for Parkinson's disease. J Neurochem 82:458-467
36. Schmidt J, Mertz K, Morgan JI (1999) Regulation of heme oxygenase-1 expression by dopamine in cultured C6 glioma and primary astrocytes. Mol Brain Res 73:50-59
37. Marklund SL (1990) Expression of extracellular superoxide dismutase by human cell lines. Biochem J 266:213-219
38. Shih AY, Erb H, Murphy TH (2007) Dopamine activates Nrf2-regulated neuroprotective pathways in astrocytes and meningeal cells. J Neurochem 101:109-119